Rowinski Group Awarded National Certification from the Women’s Business Enterprise National Council

January 2020
Rowinski Group LLC, a reimbursement and healthcare payer data analytics consultancy for medical device, diagnostic and digital health  companies, is proud to announce it was awarded national certification as a Women’s Business Enterprise (WBE).   As a certified Women’s Business Enterprise, Rowinski Group can assist U.S. based companies to meet their supplier diversity goals and objectives. The certification is effective January 1, 2020 and confirms Rowinski Group is at least 51% owned, operated, and controlled by women.   


Opportunity for Start-Up Funding

February 2019
The University of California-San Francisco (UCSF) Rosenman Institute provides startups with expertise and mentorship from stakeholders across the healthcare industry.  The Institute is inviting (40) startups to pitch on May 14 or 15, 2019  to a panel of judges comprised of financial/strategic investors, subject matter experts, and clinicians. The judges will select (10) startups as the 2019 Rosenman Innovators.


FDA Continues to Create More Communication Pathways Between Payors and Companies

September 2018
Rowinski Group considers the Federal Food and Drug Administration‘s (FDA) efforts to facilitate communication pathways between medical technology companies and payors relevant because the pathways may offer companies opportunities to begin reimbursement planning for their medical or digital technology well before it is cleared or approved by the FDA.


Preliminary Changes to Medicare Reimbursement for Clinicians

December 2016
We believe Medicare’s Quality Payment Program may offer unique opportunities to monetize your medical device, diagnostic test or digital health technology outside of traditional reimbursement pathways.  It takes time to determine the value of incorporating the Quality Payment Program into your product development, clinical trial, and sales efforts.

Home » Newsletter Library